Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01119560 · ClinicalTrials.gov registry record
Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 576
- Enrollment target
NCT01119560 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 576 participants.
The verdict
NCT01119560 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 576 participants
- Enrollment target
Study Summary
This research trial studies the genes biomarkers in children with neuroblastoma. Studying the genes in a child's cancer cells may help doctors improve ways to diagnose and treat children with neuroblastoma.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 576 participants |
| Start Date | 2009-02-03 |
| Est. Completion | 2018-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01119560
The ClinicalTrials.gov registry entry for NCT01119560 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 576 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01119560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01119560 about?
NCT01119560 is a clinical study titled "Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])". This research trial studies the genes biomarkers in children with neuroblastoma. Studying the genes in a child's cancer cells may help doctors improve ways to diagnose and treat children with neuroblastoma.
What is the current status of trial NCT01119560?
This trial is currently completed. The enrollment target is 576 participants. The study started on 2009-02-03. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT01119560?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT01119560?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.